Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,162 | 6,144 | 4,947 | 4,734 | 7,438 |
| TOTAL | $3,534 | $6,687 | $5,237 | $5,180 | $7,979 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,534 | $6,687 | $5,237 | $5,180 | $7,979 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 808 | 864 | 1,327 | 823 | 866 |
| Accrued Expenses | 1,165 | 1,083 | 591 | 549 | 758 |
| TOTAL | $1,973 | $1,946 | $1,918 | $1,372 | $1,624 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,973 | $1,946 | $1,918 | $1,372 | $1,624 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 543 | 204 | 132 | 44 | 44 |
| Common Shares | 0 | 0 | 0 | 1 | 0 |
| Retained earnings | -65,675 | -62,524 | -59,351 | -56,522 | -53,388 |
| TOTAL | $1,561 | $4,741 | $3,318 | $3,808 | $6,355 |
| Total Liabilities And Equity | $3,534 | $6,687 | $5,237 | $5,180 | $7,979 |